Literature DB >> 679737

Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas.

Y Rosen, T J Athanassiades, S Moon, H A Lyons.   

Abstract

Nongranulomatous, nonspecific interstitial pneumonitis was a predominating or prominent histopathologic finding in 62 percent of 128 granuloma-containing specimens from open lung biopsies obtained from patients with sarcoidosis. Data from this study, combined with observations by others on the evolution of experimentally induced granulomas, indicate that interstitial pneumonitis represents a very early lesion, possibly the initial lesion, in pulmonary sarcoidosis. Because of the relatively large error of sampling inherent in the currently increasing practice of obtaining small specimens for lung biopsy via the flexible fiberoptic bronchoscope, we anticipate that interstitial pneumonitis will be seen as the only histopathologic finding in these specimens with increasing frequency. It is therefore important to recognize that interstitial pneumonitis is a characteristic, although nondiagnostic, morphologic feature of pulmonary sarcoidosis.

Entities:  

Mesh:

Year:  1978        PMID: 679737     DOI: 10.1378/chest.74.2.122

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Bronchoalveolar lavage.

Authors:  J Golden
Journal:  West J Med       Date:  1986-09

2.  Suppression of the alveolitis in pulmonary sarcoidosis by oral corticosteroids.

Authors:  G A Rossi; G B Di Negro; E Balzano; E Cerri; O Sacco; B Balbi; A Venturini; R Ramoino; C Ravazzoni
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 3.  Bronchoalveolar T lymphocytes and pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Clin Rev Allergy       Date:  1985-05

Review 4.  Alveolitis: the key to the interstitial lung disorders.

Authors:  B A Keogh; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

5.  Prognosis in sarcoidosis.

Authors:  J T Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

6.  Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.

Authors:  G A Rossi; O Sacco; E Cosulich; G Damiani; G Corte; A Bargellesi; C Ravazzoni
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

7.  Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and microangiopathy in transbronchial lung biopsies.

Authors:  T Takemura; Y Matsui; M Oritsu; O Akiyama; Y Hiraga; M Omichi; M Hirasawa; S Saiki; S Tamura; I Mochizuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

Authors:  A Venet; A J Hance; C Saltini; B W Robinson; R G Crystal
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.

Authors:  G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.